{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:44:53Z","timestamp":1793677493147,"version":"4.5.1"},"reference-count":201,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","gastrojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1053\/j.gastro.2017.07.049","type":"journal-article","created":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T06:30:22Z","timestamp":1501914622000},"page":"302-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":305,"title":["Management of Gastroesophageal Reflux Disease"],"prefix":"10.1053","volume":"154","author":[{"given":"C. Prakash","family":"Gyawali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Fass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2017.07.049_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib2","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1572-0241.2006.00723.x","article-title":"The burden\u00a0of gastrointestinal and liver diseases, 2006","volume":"101","author":"Shaheen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib3","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/archinte.159.18.2161","article-title":"Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease","volume":"159","author":"Fass","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2036.2000.00733.x","article-title":"The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis","volume":"14","author":"Fass","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis\u00a0and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nmo.13067","article-title":"Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group","volume":"29","author":"Roman","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.cgh.2014.08.029","article-title":"Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease","volume":"13","author":"Patel","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/nmo.12745","article-title":"GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation","volume":"28","author":"Patel","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib9","doi-asserted-by":"crossref","unstructured":"Aziz Q, Fass R, Gyawali CP, et\u00a0al. Functional esophageal disorders [published online ahead of print February 15, 2016]. Gastroenterology https:\/\/doi.org\/10.1053\/j.gastro.2016.02.012.","DOI":"10.1053\/j.gastro.2016.02.012"},{"key":"10.1053\/j.gastro.2017.07.049_bib10","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/nmo.12838","article-title":"Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring","volume":"28","author":"Patel","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cgh.2011.12.020","article-title":"Alternative therapeutic approaches to chronic proton pump inhibitor treatment","volume":"10","author":"Fass","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach","volume":"166","author":"Kaltenbach","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib13","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s10620-008-0413-9","article-title":"The association between obesity and GERD: a review of the epidemiological evidence","volume":"53","author":"El-Serag","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2017.07.049_bib14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1572-0241.2005.41703.x","article-title":"Obesity is an independent risk factor for GERD symptoms and erosive esophagitis","volume":"100","author":"El-Serag","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s11605-009-0930-7","article-title":"Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms","volume":"13","author":"Ayazi","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib16","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1056\/NEJMoa054391","article-title":"Body-mass index and symptoms of gastroesophageal reflux in women","volume":"354","author":"Jacobson","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib17","first-page":"1168","article-title":"[Nutrition and health\u2013ideal body weight for the obese unrealistic; health benefit by moderate sustained weight loss]","volume":"147","author":"Mathus-Vliegen","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1053\/j.gastro.2017.07.049_bib18","first-page":"635","article-title":"Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension","volume":"8","author":"Mathus-Vliegen","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/003655299750026326","article-title":"Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight","volume":"34","author":"Fraser-Moodie","year":"1999","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1053\/j.gastro.2017.07.049_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13009","article-title":"Weight loss and waist reduction is associated with improvement in gastroesophageal disease reflux symptoms: A longitudinal study of 15 295 subjects undergoing health checkups","volume":"29","author":"Park","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1572-0241.2003.07531.x","article-title":"Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association","volume":"98","author":"Shaker","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004836-199406000-00004","article-title":"Body position affects recumbent postprandial reflux","volume":"18","author":"Katz","year":"1994","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib23","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1572-0241.1999.01279.x","article-title":"Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease","volume":"94","author":"Khoury","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib24","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/S0002-9270(00)01973-0","article-title":"Effect of different recumbent positions on postprandial gastroesophageal reflux in normal subjects","volume":"95","author":"van Herwaarden","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gtc.2012.11.011","article-title":"Gastroesophageal reflux disease and sleep","volume":"42","author":"Fujiwara","year":"2013","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2017.07.049_bib26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1365-2036.1998.00407.x","article-title":"Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression","volume":"12","author":"Orr","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/00365520310004506","article-title":"Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men","volume":"38","author":"Watanabe","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib28","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/gut.2004.043265","article-title":"Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux","volume":"53","author":"Nilsson","year":"2004","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib29","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/0016-5085(87)90634-2","article-title":"Influence of smoking and esophageal intubation on esophageal pH-metry","volume":"92","author":"Schindlbeck","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib30","first-page":"1076","article-title":"The immediate effects of cessation of cigarette smoking on gastroesophageal reflux","volume":"84","author":"Waring","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0773.1993.tb01340.x","article-title":"Oesophageal and gastric potential difference and pH in healthy volunteers following intake of coca-cola, red wine, and alcohol","volume":"72","author":"Rubinstein","year":"1993","journal-title":"Pharmacol Toxicol"},{"key":"10.1053\/j.gastro.2017.07.049_bib32","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1023\/A:1018893721735","article-title":"Effects of red wine on 24-hour esophageal pH and pressures in healthy volunteers","volume":"42","author":"Grande","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2017.07.049_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/gut.38.5.655","article-title":"High amplitude contractions in the middle third of the oesophagus: a\u00a0manometric marker of chronic alcoholism?","volume":"38","author":"Grande","year":"1996","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ajg.2015.322","article-title":"ACG clinical guideline: diagnosis and management of Barrett's esophagus","volume":"111","author":"Shaheen","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2013.226450","article-title":"Barrett esophagus and risk of esophageal cancer: a clinical review","volume":"310","author":"Spechler","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.07.049_bib36","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib37","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/gast.2001.24840","article-title":"Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole","volume":"120","author":"Vela","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib38","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.cgh.2006.09.013","article-title":"Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials","volume":"4","author":"Gralnek","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib39","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review\u00a0and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12916-017-0804-x","article-title":"When is proton pump inhibitor use appropriate?","volume":"15","author":"Yadlapati","year":"2017","journal-title":"BMC Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib41","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association Medical Position Statement\u00a0on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib42","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-140-7-200404060-00011","article-title":"Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics","volume":"140","author":"Numans","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2982.2012.01888.x","article-title":"PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis","volume":"24","author":"Weijenborg","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.dld.2012.11.017","article-title":"Predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease","volume":"45","author":"Wang","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2017.07.049_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/nmo.12221","article-title":"Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?","volume":"26","author":"de Bortoli","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib46","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cgh.2011.07.009","article-title":"Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease","volume":"9","author":"Slaughter","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib47","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/gut.2004.054981","article-title":"Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole","volume":"54","author":"Taghavi","year":"2005","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib48","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/ajg.2009.646","article-title":"Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain","volume":"105","author":"Kushnir","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1053\/j.gastro.2017.07.049_bib49","article-title":"Medical treatments in the short term management of reflux oesophagitis","author":"Khan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2017.07.049_bib50","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib51","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1001\/archinte.1991.00400120040007","article-title":"Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group","volume":"151","author":"Sabesin","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib52","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","article-title":"Effectiveness of proton pump inhibitors in nonerosive reflux disease","volume":"2","author":"Dean","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1572-0241.2001.03443.x","article-title":"Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"96","author":"Johnson","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1053\/j.gastro.2017.07.049_bib54","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"Sigterman","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2017.07.049_bib55","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/ajg.2011.146","article-title":"Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease","volume":"106","author":"Kahrilas","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib56","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cgh.2012.01.022","article-title":"Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease","volume":"10","author":"Kahrilas","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib57","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/gut.2011.241307","article-title":"Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease","volume":"60","author":"Kahrilas","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib58","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1572-0241.2005.41657.x","article-title":"Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis","volume":"100","author":"Cremonini","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib59","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/archinte.165.11.1222","article-title":"Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain? A meta-analysis","volume":"165","author":"Wang","year":"2005","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1053\/j.gastro.2017.07.049_bib60","article-title":"Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults","author":"Chang","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2017.07.049_bib61","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.mlg.0000192173.00498.ba","article-title":"Treatment of chronic posterior laryngitis with esomeprazole","volume":"116","author":"Vaezi","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1053\/j.gastro.2017.07.049_bib62","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MCG.0b013e3181b8e97b","article-title":"Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough","volume":"44","author":"Hersh","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib63","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/rccm.200507-1167OC","article-title":"Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial","volume":"173","author":"Kiljander","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1053\/j.gastro.2017.07.049_bib64","article-title":"Deprescribing versus continuation of chronic proton pump inhibitor use in adults","author":"Boghossian","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2017.07.049_bib65","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2009.556","article-title":"Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system","volume":"105","author":"Vasiliadis","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40265-017-0712-6","article-title":"The safety of appropriate use of over-the-counter proton pump inhibitors: an evidence-based review and Delphi consensus","volume":"77","author":"Johnson","year":"2017","journal-title":"Drugs"},{"key":"10.1053\/j.gastro.2017.07.049_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and safe proton pump inhibitor therapy in acid-related diseases. A\u00a0position paper addressing benefits and potential harms\u00a0of acid suppression","volume":"14","author":"Scarpignato","year":"2016","journal-title":"BMC Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrgastro.2016.44","article-title":"Therapy: Risks associated with chronic PPI use\u2014signal or noise?","volume":"13","author":"Kia","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib70","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00535-005-1704-y","article-title":"\u201cProton-pump inhibitor-first\u201d strategy versus \u201cstep-up\u201d strategy for the\u00a0acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan","volume":"40","author":"Habu","year":"2005","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib71","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/gast.2001.28649","article-title":"Step-down management of gastroesophageal reflux disease","volume":"121","author":"Inadomi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib72","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5414\/CP202564","article-title":"Comparative effectiveness of histamine-2 receptor antagonists as short-term therapy for gastro-esophageal reflux disease: a network\u00a0meta-analysis","volume":"54","author":"Zhao","year":"2016","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib73","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/phar.1665","article-title":"Concomitant administration of a histamine2 receptor antagonist and proton pump inhibitor enhances gastric acid suppression","volume":"35","author":"Abdul-Hussein","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.gastro.2017.07.049_bib74","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MCG.0b013e31814a4e5c","article-title":"Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough","volume":"42","author":"Mainie","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib75","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/gast.2002.31876","article-title":"Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough","volume":"122","author":"Fackler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2036.2003.01394.x","article-title":"Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH","volume":"17","author":"Vela","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib77","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3748\/wjg.v20.i9.2412","article-title":"Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis","volume":"20","author":"Ren","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib78","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/gutjnl-2011-301898","article-title":"Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?","volume":"61","author":"Kahrilas","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib79","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1365-2036.2002.01325.x","article-title":"The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease","volume":"16","author":"van Herwaarden","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib80","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/ajg.2009.247","article-title":"Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?","volume":"104","author":"Beaumont","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365528909093066","article-title":"Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis","volume":"24","author":"Weberg","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib82","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365528509089680","article-title":"Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial","volume":"20","author":"Grove","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib83","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cgh.2013.04.046","article-title":"An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease","volume":"11","author":"Rohof","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib84","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.3748\/wjg.v18.i32.4371","article-title":"Alginate controls heartburn in patients with erosive and nonerosive reflux disease","volume":"18","author":"Savarino","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dow020","article-title":"Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis","volume":"30","author":"Leiman","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1053\/j.gastro.2017.07.049_bib86","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1442-2050.2011.01276.x","article-title":"Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial","volume":"25","author":"Manabe","year":"2012","journal-title":"Dis Esophagus"},{"key":"10.1053\/j.gastro.2017.07.049_bib87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0736-4679(03)00196-3","article-title":"The GI Cocktail is no\u00a0more effective than plain liquid antacid: a randomized, double blind clinical trial","volume":"25","author":"Berman","year":"2003","journal-title":"J\u00a0Emerg Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib88","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.hlc.2014.03.030","article-title":"The use of gastrointestinal cocktail for differentiating gastro-oesophageal reflux disease and acute coronary syndrome in the emergency setting: a systematic review","volume":"23","author":"Chan","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1053\/j.gastro.2017.07.049_bib89","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.0953-0673.1996.00441.x","article-title":"Sucralfate gel versus placebo in patients with non-erosive gastro-oesophageal reflux disease","volume":"10","author":"Simon","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib90","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/apt.13611","article-title":"Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013","volume":"43","author":"Khan","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib91","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.2011.626","article-title":"Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial","volume":"305","author":"Galmiche","year":"2011","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.07.049_bib92","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/gut.2008.148833","article-title":"Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial","volume":"57","author":"Lundell","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib93","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.gassur.2006.07.010","article-title":"Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: seven-year follow-up","volume":"10","author":"Mehta","year":"2006","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib94","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11605-012-2057-5","article-title":"Gastroesophageal reflux disease and antireflux surgery\u2014what is the proper preoperative work-up?","volume":"17","author":"Bello","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib95","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jamcollsurg.2013.05.023","article-title":"Preoperative diagnostic workup before antireflux surgery: an evidence and\u00a0experience-based consensus of the Esophageal Diagnostic Advisory Panel","volume":"217","author":"Jobe","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00464-005-0174-x","article-title":"Clinical results of laparoscopic fundoplication at ten years after surgery","volume":"20","author":"Dallemagne","year":"2006","journal-title":"Surg Endosc"},{"key":"10.1053\/j.gastro.2017.07.049_bib97","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/SLA.0000000000002106","article-title":"Seventeen-year outcome of a randomized clinical trial comparing laparoscopic and conventional nissen fundoplication: a\u00a0plea for patient counseling and clarification","volume":"266","author":"Oor","year":"2017","journal-title":"Ann Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib98","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.285.18.2331","article-title":"Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial","volume":"285","author":"Spechler","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.07.049_bib99","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1091-255X(99)80071-7","article-title":"Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication","volume":"3","author":"Campos","year":"1999","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib100","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00268-013-2415-9","article-title":"Preoperative factors predicting clinical outcome following laparoscopic fundoplication","volume":"38","author":"Staehelin","year":"2014","journal-title":"World J Surg"},{"issue":"11","key":"10.1053\/j.gastro.2017.07.049_bib101","article-title":"Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults","author":"Garg","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2017.07.049_bib102","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cgh.2016.10.031","article-title":"Association between response to acid-suppression therapy and efficacy of antireflux surgery in patients with extraesophageal reflux","volume":"15","author":"Krill","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib103","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1007\/s00464-013-2959-7","article-title":"Gas-related symptoms after antireflux surgery","volume":"27","author":"Kessing","year":"2013","journal-title":"Surg Endosc"},{"key":"10.1053\/j.gastro.2017.07.049_bib104","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/ajg.2013.289","article-title":"Multiple rapid swallow responses during esophageal high-resolution manometry reflect esophageal body peristaltic reserve","volume":"108","author":"Shaker","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/nmo.12728","article-title":"Ineffective esophageal motility phenotypes following fundoplication in gastroesophageal reflux disease","volume":"28","author":"Mello","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib106","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamasurg.2014.3859","article-title":"Analysis of the causes of failed antireflux surgery and the principles of treatment: a review","volume":"150","author":"Patti","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib107","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/SLA.0000000000001139","article-title":"The impact of gastric bypass on gastroesophageal reflux disease in morbidly obese patients","volume":"263","author":"Madalosso","year":"2016","journal-title":"Ann Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib108","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/000313481408000726","article-title":"Minimally invasive Roux-en-Y gastric bypass for fundoplication failure offers excellent gastroesophageal reflux control","volume":"80","author":"Kim","year":"2014","journal-title":"Am Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.soard.2008.08.021","article-title":"Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease","volume":"5","author":"Varela","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2017.07.049_bib110","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.cgh.2016.12.019","article-title":"A\u00a0modern magnetic implant for gastroesophageal reflux disease","volume":"15","author":"Ganz","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib111","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1205544","article-title":"Esophageal sphincter device for gastroesophageal reflux disease","volume":"368","author":"Ganz","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib112","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jamcollsurg.2015.02.025","article-title":"Laparoscopic magnetic sphincter augmentation vs laparoscopic nissen fundoplication: a matched-pair analysis of 100 patients","volume":"221","author":"Reynolds","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib113","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cgh.2015.05.028","article-title":"Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux","volume":"14","author":"Ganz","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib114","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/dote.12199","article-title":"Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease","volume":"28","author":"Lipham","year":"2015","journal-title":"Dis Esophagus"},{"key":"10.1053\/j.gastro.2017.07.049_bib115","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s00464-016-5370-3","article-title":"LINX(R) magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis","volume":"31","author":"Skubleny","year":"2017","journal-title":"Surg Endosc"},{"key":"10.1053\/j.gastro.2017.07.049_bib116","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0016-5085(03)01052-7","article-title":"Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial","volume":"125","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib117","doi-asserted-by":"crossref","unstructured":"Fass R, Cahn F, Scotti DJ, et\u00a0al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease [published online ahead of print February 23, 2017]. Surg Endosc https:\/\/doi.org\/10.1007\/s00464-017-5431-2.","DOI":"10.1007\/s00464-017-5431-2"},{"key":"10.1053\/j.gastro.2017.07.049_bib118","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cgh.2014.10.013","article-title":"No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis","volume":"13","author":"Lipka","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib119","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.gastro.2014.10.009","article-title":"Efficacy of transoral fundoplication vs omeprazole for treatment of\u00a0regurgitation in a randomized controlled trial","volume":"148","author":"Hunter","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ajg.2015.28","article-title":"Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of\u00a0gastroesophageal reflux disease","volume":"110","author":"Witteman","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib121","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s00464-016-5111-7","article-title":"Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis","volume":"31","author":"Huang","year":"2017","journal-title":"Surg Endosc"},{"key":"10.1053\/j.gastro.2017.07.049_bib122","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1442-2050.2011.01322.x","article-title":"Step-by-step management of refractory gastresophageal reflux disease","volume":"26","author":"Hershcovici","year":"2013","journal-title":"Dis Esophagus"},{"key":"10.1053\/j.gastro.2017.07.049_bib123","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2036.2010.04406.x","article-title":"Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies","volume":"32","author":"El-Serag","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib124","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1365-2036.2006.02911.x","article-title":"Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease","volume":"23","author":"Gunaratnam","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","article-title":"Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease\u2014where next?","volume":"22","author":"Fass","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib126","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5056\/jnm15105","article-title":"Unmet needs in the treatment of gastroesophageal reflux disease","volume":"21","author":"Dickman","year":"2015","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib127","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2036.2006.02982.x","article-title":"Persistence and adherence to proton pump inhibitors in\u00a0daily clinical practice","volume":"24","author":"Van Soest","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib128","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/j.1365-2036.2010.04469.x","article-title":"The effects of dose and timing of esomeprazole administration on 24-h, daytime and night-time acid inhibition in healthy volunteers","volume":"32","author":"Wilder-Smith","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib129","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ajg.2013.421","article-title":"Consumer use of over-the-counter proton pump inhibitors in patients with\u00a0gastroesophageal reflux disease","volume":"109","author":"Sheikh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib130","doi-asserted-by":"crossref","unstructured":"Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease [published online ahead of print April 24, 2017]. Gut Liver https:\/\/doi.org\/10.5009\/gnl16615.","DOI":"10.5009\/gnl16615"},{"key":"10.1053\/j.gastro.2017.07.049_bib131","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cgh.2008.02.016","article-title":"Persistent heartburn in a patient on proton-pump inhibitor","volume":"6","author":"Fass","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib132","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of\u00a0severe peptic esophagitis after treatment with omeprazole","volume":"95","author":"Hetzel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib133","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1046\/j.1365-2036.2000.00882.x","volume":"14","author":"Fass","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib134","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ajg.2012.19","article-title":"Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: the Japan-based TWICE study","volume":"107","author":"Kinoshita","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib135","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/apt.12014","article-title":"Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype","volume":"36","author":"Sugimoto","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib136","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-3565(05)00860-8","article-title":"Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial","volume":"4","author":"Fass","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib137","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cgh.2011.11.021","article-title":"Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release","volume":"10","author":"Fass","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib138","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/apt.13567","article-title":"Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor","volume":"43","author":"Reimer","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib139","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5056\/jnm16100","article-title":"A\u00a0double-blind, randomized, multicenter clinical trial investigating the efficacy and safety of esomeprazole single therapy versus mosapride and esomeprazole combined therapy in patients with esophageal reflux disease","volume":"23","author":"Lee","year":"2017","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/apt.12363","article-title":"Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease\u2014insights into study design for transient lower sphincter relaxation inhibitors","volume":"38","author":"Vakil","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib141","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jpsychores.2013.08.008","article-title":"Psychological distress is\u00a0not associated with treatment failure in patients with gastroesophageal reflux disease","volume":"75","author":"Boltin","year":"2013","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1053\/j.gastro.2017.07.049_bib142","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2036.2008.03883.x","article-title":"Review article: gastro-oesophageal reflux disease and psychological comorbidity","volume":"29","author":"Mizyed","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib143","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2007.12.010","article-title":"The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease","volume":"134","author":"Fass","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib144","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10620-017-4475-4","article-title":"Psychological comorbidity and chronic heartburn: which is the chicken and which is the egg?","volume":"62","author":"Fass","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2017.07.049_bib145","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gutjnl-2011-301897","article-title":"Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors","volume":"61","author":"Sifrim","year":"2012","journal-title":"Gut"},{"issue":"Suppl 3","key":"10.1053\/j.gastro.2017.07.049_bib146","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-1746.2012.07064.x","article-title":"Therapeutic options for refractory gastroesophageal reflux disease","volume":"27","author":"Fass","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib147","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","article-title":"Management of heartburn not responding to proton pump inhibitors","volume":"58","author":"Fass","year":"2009","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib148","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MOG.0b013e32833ae2be","article-title":"Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors","volume":"26","author":"Hershcovici","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib149","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11894-008-0052-5","article-title":"Refractory GERD: what is it?","volume":"10","author":"Fass","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1053\/j.gastro.2017.07.049_bib150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2036.2003.01423.x","article-title":"Non-erosive reflux disease (NERD)\u2014acid reflux and symptom patterns","volume":"17","author":"Martinez","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib151","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00535-011-0480-0","article-title":"Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients","volume":"47","author":"Savarino","year":"2012","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib152","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.dld.2011.01.016","article-title":"The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease","volume":"43","author":"Savarino","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2017.07.049_bib153","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/nmo.12666","article-title":"Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux","volume":"27","author":"Roman","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib154","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gie.2009.08.024","article-title":"Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment","volume":"71","author":"Poh","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2017.07.049_bib155","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gutjnl-2013-306393","article-title":"Symptomatic reflux disease: the present, the past and the future","volume":"63","author":"Boeckxstaens","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib156","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/nmo.12644","article-title":"Patients with refractory reflux symptoms: What do they have and how should they be managed?","volume":"27","author":"Kahrilas","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib157","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/nmo.12611","article-title":"Pathophysiology of gastroesophageal reflux disease: new understanding in a new era","volume":"27","author":"Herregods","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib158","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/ajg.2009.240","article-title":"Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily","volume":"104","author":"Gasiorowska","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib159","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/nmo.12339","article-title":"The role of pain modulators in esophageal disorders\u2014no pain no gain","volume":"26","author":"Dickman","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib160","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0016-5085(87)90979-6","article-title":"Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial","volume":"92","author":"Clouse","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.049_bib161","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM199405193302003","article-title":"Imipramine in patients with chest pain despite normal coronary angiograms","volume":"330","author":"Cannon","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.07.049_bib162","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/euhj.1997.0615","article-title":"Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms","volume":"19","author":"Cox","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1053\/j.gastro.2017.07.049_bib163","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ajg.2015.413","article-title":"Imipramine for treatment of esophageal hypersensitivity and functional heartburn: a randomized placebo-controlled trial","volume":"111","author":"Limsrivilai","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib164","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.3748\/wjg.v19.i30.4958","article-title":"Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain","volume":"19","author":"Park","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib165","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.3748\/wjg.v19.i42.7455","article-title":"Effect of low-dose amitriptyline on globus pharyngeus and its side effects","volume":"19","author":"You","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib166","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mhj.2000.108514","article-title":"Randomized trial of sertraline in patients with unexplained chest pain of\u00a0noncardiac origin","volume":"140","author":"Varia","year":"2000","journal-title":"Am Heart J"},{"key":"10.1053\/j.gastro.2017.07.049_bib167","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.pain.2010.08.040","article-title":"Effects of coping skills training and sertraline in patients with non-cardiac chest pain: a randomized controlled study","volume":"152","author":"Keefe","year":"2011","journal-title":"Pain"},{"key":"10.1053\/j.gastro.2017.07.049_bib168","first-page":"15","article-title":"A\u00a0randomized controlled trial of paroxetine for noncardiac chest pain","volume":"39","author":"Doraiswamy","year":"2006","journal-title":"Psychopharmacol Bull"},{"key":"10.1053\/j.gastro.2017.07.049_bib169","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jpsychores.2010.02.005","article-title":"Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine","volume":"69","author":"Spinhoven","year":"2010","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1053\/j.gastro.2017.07.049_bib170","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2036.2006.02772.x","article-title":"Influence of citalopram, a selective serotonin reuptake inhibitor, on\u00a0oesophageal hypersensitivity: a double-blind, placebo-controlled study","volume":"23","author":"Broekaert","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib171","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/nmo.12313","article-title":"Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial","volume":"26","author":"Ostovaneh","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib172","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/ajg.2010.82","article-title":"Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial","volume":"105","author":"Lee","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib173","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1572-0241.2007.01112.x","article-title":"Theophylline improves esophageal chest pain\u2013a randomized, placebo-controlled study","volume":"102","author":"Rao","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib174","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/000348941312200803","article-title":"Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin","volume":"122","author":"Kirch","year":"2013","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1053\/j.gastro.2017.07.049_bib175","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/gut.2004.048884","article-title":"Use of psychopharmacological agents for functional gastrointestinal disorders","volume":"54","author":"Clouse","year":"2005","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib176","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1365-2036.2004.02217.x","article-title":"A\u00a0single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn","volume":"20","author":"Rodriguez-Stanley","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib177","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cgh.2006.01.014","article-title":"Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity","volume":"4","author":"Rodriguez-Stanley","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.049_bib178","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4236\/ojgas.2014.42010","article-title":"The effect of melatonin in functional heartburn: a randomized, placebo-controlled clinical trial","volume":"2014","author":"Basu","year":"2014","journal-title":"Op J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib179","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/dote.12353","article-title":"Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn","volume":"29","author":"Riehl","year":"2016","journal-title":"Dis Esophagus"},{"key":"10.1053\/j.gastro.2017.07.049_bib180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/gut.35.4.447","article-title":"Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease","volume":"35","author":"Marrero","year":"1994","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib181","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/bjs.5493","article-title":"Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication","volume":"93","author":"Mainie","year":"2006","journal-title":"Br J Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib182","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.2010.224824","article-title":"Effects of anti-reflux surgery on weakly acidic reflux and belching","volume":"60","author":"Broeders","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.049_bib183","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/ajg.2011.179","article-title":"Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study","volume":"107","author":"Viazis","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib184","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1365-2036.2007.03520.x","article-title":"Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn","volume":"26","author":"Dickman","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib185","first-page":"4547","article-title":"Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review","volume":"20","author":"Casale","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1053\/j.gastro.2017.07.049_bib186","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5056\/jnm.2014.20.1.6","article-title":"New and future drug development for gastroesophageal reflux disease","volume":"20","author":"Maradey-Romero","year":"2014","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib187","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/MCG.0000000000000125","article-title":"Nonmedical therapeutic strategies for nonerosive reflux disease","volume":"48","author":"Maradey-Romero","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib188","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pharmthera.2005.05.005","article-title":"Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases","volume":"108","author":"Andersson","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib189","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40262-015-0326-7","article-title":"The first-in-class potassium-competitive acid blocker, vonoprazan fumarate: pharmacokinetic and pharmacodynamic considerations","volume":"55","author":"Echizen","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1053\/j.gastro.2017.07.049_bib190","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.13461","article-title":"Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis","volume":"43","author":"Ashida","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.049_bib191","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1572-0241.2007.01544.x","article-title":"A\u00a0randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease","volume":"103","author":"Dent","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib192","unstructured":"Morrison T. Ironwood Pharmaceuticals. Ironwood reports\u00a0positive top-line data from exploratory Phase IIa trial of IW-3718 in refractory gastroesophageal reflux disease. Available at: http:\/\/investor.ironwoodpharma.com\/releasedetail.cfm?ReleaseID=894586."},{"key":"10.1053\/j.gastro.2017.07.049_bib193","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3748\/wjg.v19.i2.319","article-title":"Anesthetic management of the SRS Endoscopic Stapling System for gastro-esophageal reflux disease","volume":"19","author":"Topuz","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.049_bib194","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00464-014-3731-3","article-title":"Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial","volume":"29","author":"Zacherl","year":"2015","journal-title":"Surg Endosc"},{"key":"10.1053\/j.gastro.2017.07.049_bib195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.gie.2008.07.034","article-title":"A\u00a0new injectable agent for the treatment of GERD: results of the Durasphere pilot trial","volume":"69","author":"Ganz","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2017.07.049_bib196","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0002-9610(68)90191-8","article-title":"The prevention of experimentally induced reflux by electrical stimulation of the distal esophagus","volume":"115","author":"Ellis","year":"1968","journal-title":"Am J Surg"},{"key":"10.1053\/j.gastro.2017.07.049_bib197","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2006-945102","article-title":"An endoscopically implantable device stimulates the lower esophageal sphincter on demand by remote control: a study using a canine model","volume":"39","author":"Clarke","year":"2007","journal-title":"Endoscopy"},{"key":"10.1053\/j.gastro.2017.07.049_bib198","doi-asserted-by":"crossref","first-page":"G389","DOI":"10.1152\/ajpgi.90201.2008","article-title":"Effect of electrical stimulation of the LES on LES pressure in a canine model","volume":"295","author":"Sanmiguel","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.gastro.2017.07.049_bib199","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2982.2012.01878.x","article-title":"Short-term electrical stimulation of the lower esophageal sphincter increases sphincter pressure in patients with gastroesophageal reflux disease","volume":"24","author":"Rodriguez","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2017.07.049_bib200","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00464-012-2561-4","article-title":"Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: final results of open-label prospective trial","volume":"27","author":"Rodriguez","year":"2013","journal-title":"Surg Endosc"},{"key":"10.1053\/j.gastro.2017.07.049_bib201","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1055\/s-0033-1344213","article-title":"Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease","volume":"45","author":"Rodriguez","year":"2013","journal-title":"Endoscopy"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517359899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517359899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T07:50:29Z","timestamp":1602661829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508517359899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":201,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0016508517359899"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2017.07.049","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Gastroesophageal Reflux Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2017.07.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}